(lp0
S"Analysts mean rating score stands at 2.10 while Biogen Inc.'s  stock ... Hot Stocks Point - Dec 21, 2016 Biogen Inc.  ended its day with loss -0.16% and finalized at the price of $292.47. During its last trading session, Stock traded with the total exchanged volume of 0.8 million shares."
p1
aS"Biogen Inc.  Pulled Back Sharply After Downgrade RTT News - Mar 17, 2017 Morgan Stanley downgraded its rating on shares of Biogen Inc.  Thursday morning to &quot;Equal weight&quot; from &quot;Overweight.Why Guess?, Inc. , Biogen Inc  and Snap Inc  Are 3 of Today's ... - Investorplace.comBiogen Inc  Appoints Anirvan Ghosh As SVP, Research and Early ... - StockNewsUnion"
p2
aS'Did Biogen Inc. Shoot Itself in the Foot? Motley Fool - Feb 21, 2017 Spinraza, the second drug to earn FDA approval from Ionis Pharmaceuticals  is a potential life-saver, but the enormous list price set by its marketing partner, Biogen , received icy responses from some big American health&nbsp;...'
p3
aS"Better Buy: Biogen Inc. vs. Gilead Sciences Inc. Motley Fool - Feb 27, 2017 Biogen  and Gilead Sciences  don't compete against each other -- at least not yet. Both biotechs are interested in the oncology and autoimmune disease therapeutic areas, so there's always a chance they could become rivals."
p4
aS"Drilling Down Into the Charts for Biogen Inc.  The USA Commerce - 21 hours ago We have gathered the technical data on Biogen Inc. , and see some interesting trends in the stock's behavior of late."
p5
aS'Insider Trading Activity Biogen Inc   VP Sold 9891 shares of Stock Market Exclusive - Mar 15, 2017 On 12/27/2012 Alexander J Denner, Director, sold 7,980 with an average share price of $148.62 per share and the total transaction amounting to $1,185,987.60.'
p6
aS'Get Ready For A Slew of Data As Weekend Nears Benzinga - Mar 17, 2017 A lot of commentary focused on Biogen Inc , a high-profile biotech stock that slumped 4% after a downgrade. And biotechs seemed to pull down the health care sector as a whole, with the S&amp;P Biotechnology Index falling more than 1%.'
p7
aS"Analytical Guide for Marsh &amp; McLennan Companies, Inc. , Biogen Inc. (BIIB ... The USA Commerce - Mar 16, 2017 Shares of Marsh &amp; McLennan Companies, Inc.  surged 0.13% to $74.35. During the trading on 03/15/2017, Company's stock ranged from $73.88 to $74.55."
p8
aS"Credit Suisse Anticipates Biogen Inc  Spinraza's Launch Trends to be ... Smrt Stck Nws - Mar 13, 2017 Based on recent Biogen Inc  comments, the firm thinks consensus for 1Q looks achievable. Their CEO noted on March 7th that 30 centers have dosed patients on Spinraza."
p9
aS'Biogen, Inovio Pharmaceuticals, Rubicon Project Times of India - Mar 16, 2017 March 16  - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen, Kite Pharma and Rubicon Project, on Thursday.'
p10
a.